Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-015867
Filing Date
2022-04-27
Accepted
2022-04-27 07:25:55
Documents
70
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sldb-10q_20220331.htm   iXBRL 10-Q 2258207
2 EX-31.1 sldb-ex311_11.htm EX-31.1 16300
3 EX-31.2 sldb-ex312_8.htm EX-31.2 16281
4 EX-32.1 sldb-ex321_9.htm EX-32.1 7751
5 EX-32.2 sldb-ex322_10.htm EX-32.2 7795
  Complete submission text file 0001564590-22-015867.txt   6706421

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sldb-20220331.xsd EX-101.SCH 47593
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sldb-20220331_cal.xml EX-101.CAL 41608
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sldb-20220331_def.xml EX-101.DEF 110398
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20220331_lab.xml EX-101.LAB 317025
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20220331_pre.xml EX-101.PRE 240959
64 EXTRACTED XBRL INSTANCE DOCUMENT sldb-10q_20220331_htm.xml XML 1028394
Mailing Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38360 | Film No.: 22856358
SIC: 2836 Biological Products, (No Diagnostic Substances)